Febrile Neutropenia
Febrile Neutropenia
Explore linked clinical trials. Standard reference: MESH:M057983426 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy | Blood Protein Disorders, Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, agranulocytosis, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukocyte disorder, leukopenia, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, neutropenia, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 2 | 2026-09-25 | NCT07842198 | |
| Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Recruiting | Not applicable | 2026-09-24 | NCT07372131 | |
| Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Recruiting | Phase 4 | 2026-09-18 | NCT06342115 | |
| Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSF | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, agranulocytosis, breast cancer, breast disorder, breast neoplasm, hematologic disorder, leukocyte disorder, leukopenia, neoplasm, neutropenia, skin disorder | Not yet recruiting | Not stated | 2026-09-08 | NCT07806084 | |
| Phase II Study of QLC2519 in Pediatric Solid Tumor Participants | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Recruiting | Phase 2 | 2026-07-24 | NCT07724756 | |
| Pharmacist-Led Education to Improve Neutropenic Precautions in Cancer Patients | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Active, not recruiting | Not applicable | 2026-07-08 | NCT07690956 | |
| Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Infections, Inflammation, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, agranulocytosis, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukocyte disorder, leukopenia, neoplasm, neutropenia, toxic shock syndrome | Recruiting | Not stated | 2026-06-15 | NCT07277387 | |
| Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Neoplasms by Site, agranulocytosis, childhood malignant neoplasm, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukocyte disorder, leukopenia, neoplasm, neutropenia | Not yet recruiting | Phase 4 | 2026-05-15 | NCT07590648 | |
| Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma | Cytopenia, Disease Attributes, Febrile Neutropenia, Hemic and Lymphatic Diseases, Infections, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, agranulocytosis, hematologic disorder, iatrogenic disease, leukocyte disorder, leukopenia, neoplasm, neutropenia, nosocomial infection, sarcoma | Not yet recruiting | Not applicable | 2026-04-29 | NCT06500715 | |
| Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients. | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Not yet recruiting | Phase 3 | 2026-03-19 | NCT07483736 | |
| Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Active, not recruiting | Phase 2 | 2026-03-04 | NCT03078010 | |
| Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Not yet recruiting | Not applicable | 2026-01-20 | NCT06697262 | |
| Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever | Bacterial Infections and Mycoses, Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Infections, Neoplasms by Histologic Type, agranulocytosis, bacterial infectious disease, hematologic disorder, leukemia, leukocyte disorder, leukopenia, neoplasm, neutropenia | Recruiting | Not applicable | 2025-12-15 | NCT07051525 | |
| Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Neoplasms by Site, Thoracic Neoplasms, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neoplasm, neutropenia | Recruiting | Phase 2 | 2025-12-11 | NCT07205536 | |
| Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy | Chemotherapy-Induced Febrile Neutropenia, Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Active, not recruiting | Phase 3 | 2025-11-25 | NCT06711523 | |
| Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients. | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Recruiting | Not stated | 2025-10-02 | NCT07204522 | |
| Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, agranulocytosis, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, leukocyte disorder, leukopenia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myeloid leukemia, neoplasm, neutropenia, non-Hodgkin lymphoma | Recruiting | Phase 4 | 2025-08-22 | NCT07016165 | |
| Next-Generation-Sequencing Approach to Neutropenic Sepsis | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Recruiting | Not stated | 2025-08-08 | NCT05815628 | |
| Comparison of G-CSF & Antibiotics Versus Antibiotics Alone in Resolution of Febrile Neutropenia | Chemotherapy-Induced Febrile Neutropenia, Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Not yet recruiting | Phase 4 | 2025-05-25 | NCT06988826 | |
| Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Recruiting | Not applicable | 2025-02-18 | NCT04270786 | |
| Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, agranulocytosis, hematologic disorder, immune system disorder, immunoproliferative disorder, leukocyte disorder, leukopenia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, neutropenia, non-Hodgkin lymphoma | Not yet recruiting | Phase 4 | 2025-01-28 | NCT06665737 | |
| Antibiotic Stewardship in Suspected Neutropenic Fever (ASTERIC Trial) | Cytopenia, Disease Attributes, Emergencies, Febrile Neutropenia, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, agranulocytosis, carcinoma, epithelial neoplasm, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukocyte disorder, leukopenia, neoplasm, neutropenia | Not yet recruiting | Not applicable | 2025-01-27 | NCT06794320 | |
| Effect of the BioFire FilmArray (BCID2) for the Rapid Detection of Bloodstream Infection in Haematologic Patients With Febrile Neutropenia | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Infections, Neoplasms by Site, Toxemia, agranulocytosis, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukocyte disorder, leukopenia, neoplasm, neutropenia | Active, not recruiting | Not stated | 2025-01-22 | NCT06787326 | |
| Pentaglobin in CRE and PA Neutropenic Infections | Bacterial Infections and Mycoses, Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pseudomonas infection, Sepsis, Shock, Systemic Inflammatory Response Syndrome, agranulocytosis, bacterial infectious disease, gram-negative bacterial infections, hematologic disorder, leukocyte disorder, leukopenia, neutropenia, toxic shock syndrome | Active, not recruiting | Phase 2 | 2025-01-06 | NCT03494959 | |
| PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Stomatognathic Diseases, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, mouth disorder, neoplasm, neutropenia, periodontal disorder, periodontitis, plasma cell neoplasm, stomatitis | Not yet recruiting | Not applicable | 2024-06-10 | NCT06450821 |